Insider trade

Cingulate (CING)CEO bought ~$34K

Shane J. Schaffer, CEO at Cingulate, bought ~$34K of Cingulate shares.

~$34K
Approx. value · 6,809 sh @ $5.04
10K
Holds after · shares reported
Traded
Feb 6, 2026
Filed
Feb 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 15, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“As previously disclosed on August 14, 2025, the board of directors (the “Board”) of Cingulate Inc. (the “Company”) placed Shane Schaffer, the Company’s Chief Executive Officer and Chairman of the Board, on administrative leave due to a personal legal matter and appointed John.”
  2. Dec 23, 2025Company filing · Form 8-K · Unregistered sharesSold new shares without registering them
  3. Jan 27, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
  4. Feb 6, 2026 · this disclosureInsider · 4 insiders in a week, 4th time since 2021CEO purchased ~$34K of CING shares in the open market

What came next

  1. Feb 6, 2026Company filing · Form 8-K · Unregistered shares, Other newsSold new shares without registering them, and reported other company news
  2. Feb 6, 2026Insider · 3 peopleInsiders: 3 purchases (~$132K)
  3. Feb 13, 2026Company filing · Form 8-K · Unregistered shares, Executive changeChanged a top executive or board member, and sold new shares without registering them (and 2 more items)“On February 13, 2026, in connection with the second and final closing of the private placement (the “ Private Placement ”), the Company appointed Jeff Hargroves as a member of the Board of Directors (the “ Board ”) of the Company, effective immediately, to serve as a Class I director until the Company’s 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified, or until his earlier…”
  4. Mar 18, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  5. Mar 24, 2026Company filing · Form 8-K · Material agreement, Shareholder voteSigned an important agreement, and held a shareholder vote
  6. Mar 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 27, 2026, following stockholder approval of the Issuance Proposal (defined below), Zhanpeng “Frederick” Jiang was appointed as a member of the Board of Directors (the “ Board ”) of Cingulate Inc. (the “ Company ”), effective immediately, to serve as a Class I director until the Company’s 2028 Annual Meeting of Stockholders and until his successor is duly elected and qualified, or until his earlier death,…”
  7. May 14, 2026Company filing · Form 8-K · ResultsReported its results
  8. May 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“The current Class II directors of the Board of Directors (the “ Board ”) of Cingulate Inc. (the “ Company ”), Jeff Ervin and Jay Roberts, will not seek re-election when their respective terms expire at the Company’s 2026 Annual Meeting of Stockholders in an effort to reduce the size of the Board.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cingulate

OQRO holds no insider, Congress, fund or contract record for Cingulate dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CING page.

How this filing works

Other disclosures at Cingulate

Everything OQRO holds on this company is on its CING page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data